Dr Howie McKibbon, CEO of Botanix Pharmaceuticals (ASX:BOT), discusses the FDA approval and market success of Sofdra, the first new chemical entity approved for primary axillary hyperhidrosis. Launched in the US in February 2024, the treatment has seen strong prescription growth, supported by extensive insurance coverage and a high-performing sales team. The company’s strategy focuses on patient adherence, facilitated by automatic prescription refills and co-pay assistance. A newly launched digital marketing initiative aims to reach millions searching for online treatment options.
A game-changer in dermatology
- Published on March 12, 2025
- By Sharecafe Team
The launch of Sofdra and what's next for Botanix
Serving up fresh finance news, marker movers & expertise.
LinkedIn
Email
X
Recent Posts
- Tariff mayhem, Aus vulnerable from hit to global growth,...March 14, 2025
- Hot Stocks: Catalyst Metals, Cyclopharm, Tivan, Liontown...March 14, 2025
- Tin prices surge as Alphamin mine closure worsens supply...March 14, 2025
- Chinese stocks rally as policy optimism and foreign...March 14, 2025
- US tightens sanctions on Russian banks as ceasefire...March 14, 2025
All Categories
- Battery Technology (2)
- Biotechnology (101)
- brekkie wrap (74)
- Broker News (2466)
- Commodities (1680)
- Hydrogen (6)
- Lithium (106)
- Potash (11)
- Rare Earths (6)
- Renewables (35)
- Company (7)
- Corporate Connect Research (24)
- Currencies (42)
- Cryptocurrencies (28)
- daily special (55)
- David Bassanese (90)
- Economics (3084)
- ESG (117)
- Etfs (500)
- EV Space (128)
- Featured (42)
- FinTech (26)
- Fixed Interest (231)
- FNN Content (6112)
- Franklin Templeton (1)
- fresh grind (252)
- fundie guide (22)
- Funds (1422)
- Gavin Wendt (141)
- Greg Tolpigin (75)
- hot stocks (52)
- Infrastructure (28)
- Interest Rates (386)
- investor blend (43)
- IPOs (20)
- James Dunn (185)
- Kris Walesby (67)
- LICs (162)
- Marc Sinatra (4)
- market mocha (364)
- Market Reports Text (283)
- Markets (14003)
- Media (71)
- Noosa Mining Conference (29)
- Podcasts (1)
- Politics (53)
- Product Profiles (23)
- Property (225)
- Reports (511)
- Retail (254)
- round table (8)
- Shane Oliver (260)
- Shares (18215)
- Stocks of the Hour (300)
- sip & learn (23)
- sip and learn (23)
- Sponsored Content (32)
- Strategy (204)
- Super (36)
- table for two (22)
- Technical Analysis (5)
- Technology (419)
- The Week that Was (112)
- Tim Boreham (85)
- Uncategorized (157)
- Video (4332)
- Webinars (195)
- Weekly Wrap (831)